News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
New Enterprise Associates 14, L.P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/13/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 10/06/2023 |
3
| New Enterprise Associates 14, L.P. (10% Owner) has filed a Form 3 on SYNLOGIC, INC. |
| 02/03/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/09/2023 |
SC 13D/A
| New Enterprise Associates 14, L.P. has filed a Schedule 13D for Oyster Point Pharma, Inc. |
| 01/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/21/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/12/2022 |
SC 13D
| New Enterprise Associates 14, L.P. reports a 15.3% stake in ZeroFox Holdings, Inc. |
| 08/05/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/24/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/25/2022 |
SC 13D/A
| New Enterprise Associates 14, L.P. reports a 7.3% stake in IMARA Inc. |
| 04/07/2022 |
4
| New Enterprise Associates 14, L.P. (10% Owner) has filed a Form 4 on IMARA Inc.|
Txns:
| Sold 439,088 shares
@ $1.0691, valued at
$469.4k
Sold 255,463 shares
@ $1.1032, valued at
$281.8k
|
|
| 02/15/2022 |
SC 13G
| New Enterprise Associates 14, L.P. reports a 29.5% stake in Tuya, Inc. |
| 01/26/2022 |
4
| New Enterprise Associates 14, L.P. (10% Owner) has filed a Form 4 on Casper Sleep Inc.|
Txns:
| Unknown transaction of 6,222,502 shares
@ $6.9, valued at
$42.9M
|
|
| 01/25/2022 |
4
| New Enterprise Associates 14, L.P. (10% Owner) has filed a Form 4 on IMARA Inc.|
Txns:
| Sold 11,622 shares
@ $1.6683, valued at
$19.4k
Sold 19,984 shares
@ $1.5521, valued at
$31k
Sold 102,952 shares
@ $1.4745, valued at
$151.8k
|
|
| 01/20/2022 |
4
| New Enterprise Associates 14, L.P. (10% Owner) has filed a Form 4 on IMARA Inc.|
Txns:
| Sold 6,848 shares
@ $1.8877, valued at
$12.9k
Sold 13,412 shares
@ $1.8203, valued at
$24.4k
Sold 6,295 shares
@ $1.8086, valued at
$11.4k
|
|
| 01/14/2022 |
4
| New Enterprise Associates 14, L.P. (10% Owner) has filed a Form 4 on IMARA Inc.|
Txns:
| Sold 4,634 shares
@ $2.0193, valued at
$9.4k
Sold 7,209 shares
@ $1.9262, valued at
$13.9k
Sold 9,707 shares
@ $1.9144, valued at
$18.6k
|
|
| 01/11/2022 |
4
| New Enterprise Associates 14, L.P. (10% Owner) has filed a Form 4 on IMARA Inc.|
Txns:
| Sold 14,600 shares
@ $2.0766, valued at
$30.3k
Sold 1,751 shares
@ $2, valued at
$3.5k
Sold 2,409 shares
@ $2.0421, valued at
$4.9k
|
|
| 01/10/2022 |
SC 13D/A
| New Enterprise Associates 14, L.P. reports a 14.1% stake in IMARA Inc. |
| 01/06/2022 |
4
| New Enterprise Associates 14, L.P. (10% Owner) has filed a Form 4 on IMARA Inc.|
Txns:
| Sold 13,459 shares
@ $2.3437, valued at
$31.5k
Sold 8,200 shares
@ $2.2487, valued at
$18.4k
Sold 10,257 shares
@ $2.1649, valued at
$22.2k
|
|
| 01/05/2022 |
SC 13D/A
| New Enterprise Associates 14, L.P. has filed a Schedule 13D for Lumos Pharma, Inc. |
| 01/03/2022 |
4
| New Enterprise Associates 14, L.P. (10% Owner) has filed a Form 4 on IMARA Inc.|
Txns:
| Sold 21,858 shares
@ $2.2905, valued at
$50.1k
Sold 49,953 shares
@ $2.2503, valued at
$112.4k
Sold 44,665 shares
@ $2.3373, valued at
$104.4k
|
|
| 12/29/2021 |
4
| New Enterprise Associates 14, L.P. (10% Owner) has filed a Form 4 on IMARA Inc.|
Txns:
| Sold 27,651 shares
@ $2.4233, valued at
$67k
Sold 24,580 shares
@ $2.3409, valued at
$57.5k
Sold 15,196 shares
@ $2.3002, valued at
$35k
|
|
| 12/27/2021 |
4
| New Enterprise Associates 14, L.P. (10% Owner) has filed a Form 4 on IMARA Inc.|
Txns:
| Sold 5,666 shares
@ $2.9462, valued at
$16.7k
Sold 8,667 shares
@ $2.8316, valued at
$24.5k
Sold 17,501 shares
@ $2.8317, valued at
$49.6k
Sold 15,093 shares
@ $2.5603, valued at
$38.6k
Sold 28,817 shares
@ $2.2794, valued at
$65.7k
Sold 44,993 shares
@ $2.2347, valued at
$100.5k
Sold 47,000 shares
@ $2.2103, valued at
$103.9k
Sold 38,123 shares
@ $2.3272, valued at
$88.7k
Sold 41,222 shares
@ $2.3241, valued at
$95.8k
Sold 20,109 shares
@ $2.3213, valued at
$46.7k
Sold 23,961 shares
@ $2.41, valued at
$57.7k
|
|
| 12/01/2021 |
SC 13D
| New Enterprise Associates 14, L.P. reports a 8.6% stake in NextNav Inc. |
| 11/22/2021 |
SC 13D/A
| New Enterprise Associates 14, L.P. reports a 15% stake in Casper Sleep Inc. |
| 03/10/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/10/2020 |
SC 13D/A
| New Enterprise Associates 14, L.P. has filed a Schedule 13D for Mersana Therapeutics, Inc. |
| 11/19/2020 |
SC 13D/A
| New Enterprise Associates 14, L.P. reports a 5.8% stake in Mersana Therapeutics, Inc. |
| 09/21/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/16/2020 |
4
| New Enterprise Associates 14, L.P. (10% Owner) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Disposed of 2,000,000 shares
@ $0 |
|
| 05/22/2020 |
4
| New Enterprise Associates 14, L.P. (10% Owner) has filed a Form 4 on Surface Oncology, Inc.|
Txns:
| Sold 420,000 shares
@ $3.6561, valued at
$1.5M
|
|
| 04/24/2020 |
SC 13D/A
| New Enterprise Associates 14, L.P. reports a 12.9% stake in Mersana Therapeutics, Inc. |
| 04/13/2020 |
4
| New Enterprise Associates 14, L.P. (10% Owner) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Disposed of 4,000,000 shares
@ $0 |
|
|
|
|